Novartis Oncology Universal Co-pay Program: Tabrecta

Funded
About
The Novartis Oncology Universal Co-pay Program: Tabrecta offers significant benefits for patients taking Tabrecta. This program helps commercially insured patients reduce their monthly co-pay to no more than $25, with the program contributing up to $15,000 annually. Its expansive reach across the U.S. and Puerto Rico ensures that more patients can access the life-enhancing benefits of Tabrecta, making treatment more affordable and accessible. The Novartis Oncology Universal Co-pay Program: Tabrecta also ensures automatic re-enrollment every year, providing continuous support without the need for repeated registrations.
Insurance requirements: Commercially insured
As low as: $25 per mo
Enrollment Forms
Enrollment Form
Benefits
•$15000 annual maximum benefit
Program Requirements
•Valid only for residents in the US and Puerto Rico
•Enrollment Required: Yes
•Coverage Required: No
•Needs Based: No
•Activation Required: No
Program Details
•Commercially insured patients pay no more than $25 per month; program pays up to $15,000 per calendar year
•Card can be printed for immediate use following online eligibility questions and registration
•Offer may not be combined with any other rebate, coupon, or other offer(s)
•Patient automatically reenrolled on the 1st of each calendar year if commercial insurance remains active and covers drug (Novartis copay cards DO NOT EXPIRE)
Other Programs

Assistance Fund: Non-Small Cell Lung Cancer (NSCLC)

Commercially Insured
Medicare / Medicaid

CancerCare: Non-Small Cell Lung Cancer

Medicare / Medicaid
Max Saving: $10000/year*